Cargando…
Parkinson’s Disease-Specific Autoantibodies against the Neuroprotective Co-Chaperone STIP1
Parkinson’s disease (PD) is a debilitating movement disorder characterised by the loss of dopaminergic neurons in the substantia nigra. As neuroprotective agents mitigating the rate of neurodegeneration are unavailable, the current therapies largely focus only on symptomatic relief. Here, we identif...
Autores principales: | Tan, Jolene Su Yi, Lee, Bernett, Lim, Jackwee, Ma, Dong Rui, Goh, Jia Xin, Goh, Suh Yee, Gulam, Muhammad Yaaseen, Koh, Ser Mei, Lee, Weiling Wendy, Feng, Lei, Wang, Qing, Chao, Yinxia, Rötzschke, Olaf, Tan, Eng King |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139896/ https://www.ncbi.nlm.nih.gov/pubmed/35626686 http://dx.doi.org/10.3390/cells11101649 |
Ejemplares similares
-
Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease
por: Chao, Yin-Xia, et al.
Publicado: (2020) -
Corrigendum: Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease
por: Chao, Yin-Xia, et al.
Publicado: (2020) -
Targeting the inflammasome in Parkinson’s disease
por: Su, Qi, et al.
Publicado: (2022) -
Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2017) -
New Insights into Immune-Mediated Mechanisms in Parkinson’s Disease
por: Tan, Jolene Su Yi, et al.
Publicado: (2020)